Search for a trial

A Randomized Phase 3 Study of Adagrasib in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRAS G12C Mutation with Disease Progression On or After Standard First-Line Therapy

This study has been transitioned to CTIS with ID 2023-506241-30-00 check the CTIS register for the current data. Primary objectives:To compare the efficacy of Adagrasib in combination with cetuximab versus chemotherapy (FOLFIRI or mFOLFOX6)…